| Literature DB >> 34759016 |
Li Huang1, Wenjie Xu1,2, Hongyang Liu1, Mengdi Xue1, Xiaohong Liu1, Kunli Zhang1, Liang Hu1, Jiangnan Li1, Xuemin Liu1, Zhida Xiang1,2, Jun Zheng1, Changyao Li1, Weiye Chen1, Zhigao Bu1, Tao Xiong3, Changjiang Weng4,2.
Abstract
African swine fever is a severe animal infectious disease caused by African swine fever virus (ASFV), and the morbidity and mortality associated with virulent ASFV isolates are as high as 100%. Previous studies showed that the ability of ASFV to antagonize IFN production is closely related to its pathogenicity. Here, we report that ASFV HLJ/18 infection induced low levels of type I IFN and inhibited cGMP-AMP-induced type I IFN production in porcine alveolar macrophages that were isolated from specific pathogen-free Landrace piglets. Subsequently, an unbiased screen was performed to screen the ASFV genes with inhibitory effects on the type I IFN production. ASFV pI215L, a viral E2 ubiquitin-conjugating enzyme, was identified as one of the strongest inhibitory effectors on the production of type I IFN. Knockdown of pI215L expression inhibited ASFV replication and enhanced IFN-β production. However, inhibition of type I IFN production by pI215L was independent of its E2 enzyme activity. Furthermore, we found that pI215L inhibited type I IFN production and K63-linked polyubiquitination of TANK-binding kinase 1 through pI215L-binding RING finger protein 138 (RNF138). ASFV pI215L enhanced the interaction between RNF138 and RNF128 and promoted RNF138 to degrade RNF128, which resulted in reduced K63-linked polyubiquitination of TANK-binding kinase 1 and type І IFN production. Taken together, our findings reveal a novel immune escape mechanism of ASFV, which provides a clue to the design and development of an immune-sensitive attenuated live vaccine.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34759016 DOI: 10.4049/jimmunol.2100320
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422